Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

16 Jun 2006 07:00

Embargoed Release: 07:00hrs Friday 16th June 2006 SOPHEON PLC AGM Statement At the Annual General Meeting of Sopheon plc to be held later today, theChairman of the board will give shareholders an update on the business. Thiswill include the following statement:"We are almost at the end of the first half of 2006 and in this period we havehad steady and continued development in our business. In addition to businessgenerated in our traditional territories, we are pleased to report that we havesigned our second major Accolade sale in Scandinavia, and our first in France.Our teams in the US and Europe have been able to generate 50% moreimplementation and consulting services revenue by the end of May than in thesame period last year, thanks in part to management actions taken in the secondhalf of last year. New license wins and increased recurring maintenancerevenues - which now stand at ‚£1.6m annualized - along with the step up inservices business, has put the overall business on course to significantlyimprove on the first half of 2005. However, as always I would mention that ourperformance in any reporting period can be materially affected by the signaturedate of individual deals. This factor will be a continuing consideration as webuild the business, but one that should be increasingly offset by growth.The market for product life cycle management (PLM) applications continues toexpand, with analysts forecasting compound annual growth rates ranging from 8%to 11% through 2008. More importantly, during the same period, the PLMsubmarket in which Accolade has been classified is projected to triple in size.Sopheon's offering is well positioned to take advantage of this anticipatedescalation in demand. In 2005, we strengthened our market-share in thechemicals, paper and food & beverage industries, and they remain our principaltargets. But we have also enjoyed major successes with new clients in consumerpackaged goods markets, and recently expanded our sales and marketing effortsto target manufacturers in that sector.On the product front, we have invested in the creation of a new research andapplications development (RAD) team. Its charter is to create new softwareapplications that leverage the strength of the Accolade platform and providenew sources of revenue growth. We are pleased to announce the firstapplications produced by the RAD organization, which will be introduced to themarket in the third quarter of this year: * Accolade Product Roadmapping and Planning Application - this offering will enable companies to advance the maturity of their innovation processes by making it easier for them to develop and evaluate long-term product plans, manage programs or product "families", manage product relationships, and assess the impact of dependencies among projects during portfolio analysis. * New Versions of Accolade's Stage-Gate Process and Portfolio Management Applications - these enhanced versions of existing Accolade applications will introduce new best-practice models to further support portfolio planning and the post-launch stages of product life cycle management. One important benefit of our product strategy will be to further ourrelationships with existing clients, which accounted for a quarter ofnon-recurring revenues during 2005. We expect our partners to contribute to anincrease in lead activity and sales contracts during 2006 as our resellernetwork gains additional traction and our emerging relationships with selectglobal business-management consulting partners deepen. The importance ofSopheon's ongoing relationship with Microsoft was raised to a new level withour recent promotion to the elite status of "named" partner. This advancemententitles Sopheon to the support of a Microsoft business development managerdedicated to ensuring that we receive maximum business benefit from our accessto Microsoft technical, sales and marketing resources.Sopheon also announces that it has filed a certification with the US Securitiesand Exchange Commission ("SEC") on Form 15, to immediately suspend its duty tofile reports under the Securities Act of 1934. Sopheon will realize costsavings by no longer making these filings. The certification confirms, amongother points, that Sopheon has approximately 400 US resident shareholders.These shareholders represent less than 1% of the company's issued capital, andSopheon's ordinary shares are not traded in any US markets. Sopheon beganfiling reports with the SEC following its US registration of shares issued inconnection with the acquisition of Teltech Resource Network Corporation in2000. This change will have no effect on the trading of Sopheon's shares on AIMand Euronext.Finally, we wish to inform you that Andrew Davis, a non-executive director, isretiring from the board of Sopheon as from 30 June 2006, in order to focus onhis other interests. The directors and staff thank him for his contribution tothe development of the group. This brings the overall size of the Sopheon boardto six, comprising three executive and three non-executive directors."For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Frank Jansen Citigate First Financial Tel : + 31 (0) 205 75 40 24 About SopheonSopheon (LSE:SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® system automates gate or phase-based product developmentprocesses and provides strategic decision support that allows companies toincrease revenue and profits from new products. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com.ENDSOPHEON PLC
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.